North Capital, Inc.

Position in JNJ — Johnson & Johnson

CIK 2065938 SALT LAKE CITY, UT

Position in JNJ

as of Jun 30, 2026 · filed Jul 14, 2026 Compact

Position Value

$394,669

+$20,921 QoQ

Shares Held

1,554

+1.6% QoQ

Ownership

0.000%

of shares outstanding

% of Portfolio

0.89%

of 13F equity value

Holder Rank

#3,936

of 4,676 holders

Holding Since

Mar 2025

6 quarters on record

Voting authority Sole 0% Shared 0% None 100%

Healthcare · as of Jun 30, 2026

North Capital, Inc. holds $1,795,940 across 5 Drug Manufacturers - General names. JNJ ranks #2 (22.0% of the industry book) .

#	Ticker	Company	Shares	Value (USD)
1	ABBV	AbbVie Inc.	1,920	$483,148
2	JNJ	Johnson & Johnson This page	1,554	$394,669
3	MRK	Merck & Co., Inc.	2,957	$379,974
4	LLY	ELI LILLY & Co	230	$275,868
5	GILD	Gilead Sciences, Inc.	2,076	$262,281

6 filing rows on record

Report Date	Value (USD)	Shares	Change	Type	Discretion	Filed
2026-06-30	$394,669	1,554	+1.6%	Shares	Sole	2026-07-14
2026-03-31	$373,748	1,529	0.0%	Shares	Sole	2026-04-30
2025-12-31	$316,426	1,529	-2.4%	Shares	Sole	2026-02-18
2025-09-30	$290,367	1,566	+8.4%	Shares	Sole	2025-10-09
2025-06-30	$220,723	1,445	-0.8%	Shares	Sole	2025-08-06
2025-03-31	$241,628	1,457	—	Shares	Sole	2025-04-28
No filing history on record for this holder in this stock.